N-ACETYLCYSTEINE FOR ANTI-TB DRUG-INDUCED LIVER INJURY: A RANDOMISED CONTROLLED TRIAL
First-line anti-tuberculosis (TB) therapy can cause liver injury. N-Acetylcysteine (NAC) is widely used in patients with paracetamol toxicity and there is limited evidence of benefit in liver injury due to other causes. We conducted a randomised, double-blind, placebo-controlled trial to assess whether intravenous NAC improves liver recovery in adult patients admitted to hospital with first-line…